Alnylam Pharmaceuticals, Inc. Soared
Mon, Jun 24, 2024 at 07:16 PM
Alnylam Pharmaceuticals, Inc. (ALNY:NASDAQ) rocketted at $222.9, representing a gain of 34.5%. On Mon, Jun 24, 2024, ALNY:NASDAQ hit a New 2-Week High of $222.9. The stock appeared on our News Catalysts scanner on Mon, Jun 24, 2024 at 05:05 PM in the 'MISCELLANEOUS' category. From Mon, Jun 10, 2024, the stock recorded 77.78% Up Days and 70.00% Green Days
About Alnylam Pharmaceuticals, Inc. (ALNY:NASDAQ)
Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
Top 10 Gainers:
- MicroAlgo Inc. (MLGO:NASDAQ), 288.6%
- Concord Medical Services Holdings Limited (CCM:NYSE), 108.91%
- Alimera Sciences, Inc. (ALIM:NASDAQ), 75.87%
- Agrify Corporation (AGFY:NASDAQ), 68.69%
- F45 Training Holdings Inc. (FXLV:NYSE), 57.02%
- Movella Holdings Inc Com (MVLA:NASDAQ), 50%
- Nexalin Technology Inc. (NXL:NASDAQ), 40.85%
- ATIF Holdings Limited (ATIF:NASDAQ), 38.89%
- BIOLASE, Inc. (BIOL:NASDAQ), 37.42%
- Alnylam Pharmaceuticals, Inc. (ALNY:NASDAQ), 34.52%